Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
06/06/2022 1:51 pm
Bloodwork question about BPC-157. Baseline, a fortnight in, and the numbers moved in a direction I did not expect.
If you need three other compounds to notice the first one, you have not tested the first one.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
What surprised me is how much of the perceived benefit was routine and attention rather than pharmacology.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Where does the human data stop and the extrapolation start?